4-(acetylamino)benzeneacetic acid and mirabegron

4-(acetylamino)benzeneacetic acid has been researched along with mirabegron in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwatsubo, T; Krauwinkel, W; Meijer, J; Miyashita, A; Nagata, M; Schaddelee, M; Sekiguchi, M; Suzuki, K; Takusagawa, S; Usui, T; van Gelderen, M; van Lier, JJ1

Trials

1 trial(s) available for 4-(acetylamino)benzeneacetic acid and mirabegron

ArticleYear
Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:4

    Topics: Absorption; Acetanilides; Administration, Oral; Adrenergic beta-3 Receptor Agonists; Adult; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Feces; Humans; Male; Mass Spectrometry; Metabolic Clearance Rate; Molecular Structure; Receptors, Adrenergic, beta-3; Thiazoles; Young Adult

2012